MIF expression in the rat brain: implications for neuronal function.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 2230367)

Published in Mol Med on April 01, 1998

Authors

M Bacher1, A Meinhardt, H Y Lan, F S Dhabhar, W Mu, C N Metz, J A Chesney, D Gemsa, T Donnelly, R C Atkins, R Bucala

Author Affiliations

1: Picower Institute for Medical Research, Manhasset, New York, USA.

Articles citing this

Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise. Proc Natl Acad Sci U S A (2012) 1.53

A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science (2016) 1.40

The immune system's role in the biology of autism. Curr Opin Neurol (2010) 1.31

Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J Cereb Blood Flow Metab (2010) 1.13

The conformational flexibility of the carboxy terminal residues 105-114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor. Biochemistry (2008) 1.00

Anatomical location of macrophage migration inhibitory factor in urogenital tissues, peripheral ganglia and lumbosacral spinal cord of the rat. BMC Neurosci (2003) 0.90

Serum macrophage migration inhibitory factor in the prediction of preterm delivery. Am J Obstet Gynecol (2008) 0.90

Interrelationship of cytokines, hypothalamic-pituitary-adrenal axis hormones, and psychosocial variables in the prediction of preterm birth. Gynecol Obstet Invest (2010) 0.89

Brain miffed by macrophage migration inhibitory factor. Int J Cell Biol (2012) 0.86

The role of macrophage migration inhibitory factor in Alzheimer's disease. Mol Med (2010) 0.86

MIF: mood improving/inhibiting factor? J Neuroinflammation (2014) 0.83

Macrophage migration inhibitory factor promotes proliferation and neuronal differentiation of neural stem/precursor cells through Wnt/β-catenin signal pathway. Int J Biol Sci (2013) 0.79

Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis. Pediatr Nephrol (2008) 0.78

The cytokine macrophage migration inhibitory factor (MIF) acts as a neurotrophin in the developing inner ear of the zebrafish, Danio rerio. Dev Biol (2011) 0.78

Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease. J Neuroinflammation (2015) 0.77

Down-regulation of MIF by NFκB under hypoxia accelerated neuronal loss during stroke. FASEB J (2014) 0.77

Expression of macrophage migration inhibitory factor in the mouse neocortex and posterior piriform cortices during postnatal development. Cell Mol Neurobiol (2014) 0.77

Overexpression of extracellular superoxide dismutase protects against brain injury induced by chronic hypoxia. PLoS One (2014) 0.76

The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy. Int J Tryptophan Res (2016) 0.76

Association study of MIF promoter polymorphisms with suicide completers in the Japanese population. Neuropsychiatr Dis Treat (2017) 0.75

Effect of macrophage migration inhibitory factor on corneal sensitivity after laser in situ keratomileusis in rabbit. Korean J Ophthalmol (2014) 0.75

MIF and D-DT are potential disease severity modifiers in male MS subjects. Proc Natl Acad Sci U S A (2017) 0.75

Macrophage migration inhibitory factor (MIF) modulates trophic signaling through interaction with serine protease HTRA1. Cell Mol Life Sci (2017) 0.75

Articles cited by this

Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12

Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29

In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med (1962) 11.91

The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res (1983) 7.47

MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 5.60

The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med (1994) 5.55

MIF as a glucocorticoid-induced modulator of cytokine production. Nature (1995) 5.21

An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79

Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry (1994) 3.58

Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res (1990) 2.96

Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci (1990) 2.95

Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci (1996) 2.73

Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci (1989) 2.07

Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00

An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med (1996) 1.99

A light and electron microscopic analysis of the mossy fibers of the rat dentate gyrus. J Comp Neurol (1986) 1.88

Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem (1989) 1.60

Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med (1995) 1.55

De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol (1996) 1.40

Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol (1995) 1.35

Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1997) 1.28

Glutathione binding rat liver 13k protein is the homologue of the macrophage migration inhibitory factor. Biochem Mol Biol Int (1994) 1.25

Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. Eur J Immunol (1992) 1.23

Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J Cell Biol (1990) 1.13

Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res (1990) 1.10

A simple, reliable, and sensitive method for nonradioactive in situ hybridization: use of microwave heating to improve hybridization efficiency and preserve tissue morphology. J Histochem Cytochem (1996) 1.10

Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury. Eur J Immunol (1992) 1.03

Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol. FEBS Lett (1993) 1.02

Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett (1994) 0.93

Macrophage migration inhibitory factor production by Leydig cells: evidence for a role in the regulation of testicular function. Endocrinology (1996) 0.91

Presence of macrophage migration inhibitory factor (MIF) in ependyma, astrocytes and neurons in the bovine brain. Neurosci Lett (1996) 0.87

Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neurosci Lett (1992) 0.87

A single social stress-experience alters glutamate receptor-binding in rat hippocampal CA3 area. Neurosci Lett (1993) 0.84

Induction of interleukin-1 beta mRNA in adult rat brain. Brain Res Mol Brain Res (1991) 0.81

Articles by these authors

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24

Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol (2001) 7.40

An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem (1994) 6.31

MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 5.60

The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med (1994) 5.55

MIF as a glucocorticoid-induced modulator of cytokine production. Nature (1995) 5.21

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41

Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med (2000) 3.89

An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest (1994) 3.70

Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry (1994) 3.58

Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24

The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev (1997) 3.23

Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol (1998) 3.09

Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int (1999) 3.09

Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem (1992) 3.06

Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med (1997) 2.98

Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of the frequency of donor lymphocytes which respond to each Ag-B-determined antigenic complex. J Exp Med (1975) 2.78

A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem (1995) 2.71

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature (1996) 2.71

The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats. J Exp Med (1972) 2.66

Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem (1999) 2.60

Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol (1988) 2.58

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A (1997) 2.53

Specific unresponsiveness of recirculating lymphocytes ater exposure to histocompatibility antigen in F 1 hybrid rats. Nat New Biol (1971) 2.50

The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A (1997) 2.36

Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35

The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci U S A (2003) 2.29

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int (2006) 2.22

A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun (2002) 2.21

The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med (1996) 2.21

Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol (2001) 2.20

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20

Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17

An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med (1999) 2.10

Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A (1997) 2.10

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A (1992) 2.09

Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.09

Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene (2007) 2.08

Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress. Neuroscience (1997) 2.03

Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis. J Exp Med (1978) 2.02

Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00

An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med (1996) 1.99

Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol (1997) 1.98

Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98

Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1996) 1.95

Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J (2001) 1.91

The macrophagen in human rapidly progressive glomerulonephritis. Lancet (1976) 1.88

Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun (1998) 1.87

Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol (1997) 1.86

The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med (1997) 1.86

Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest (1998) 1.85

Glomerulonephritis. Lancet (2005) 1.81

Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci U S A (2005) 1.79

De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res (2000) 1.78

An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci U S A (1999) 1.74

PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.69

Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene (2006) 1.68

Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int (2007) 1.66

Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol (2001) 1.65

Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet (1996) 1.63

Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J Immunol (1998) 1.63

Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest (1999) 1.62

Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int (2001) 1.60

The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family. J Biol Chem (1997) 1.60